This Frost & Sullivan research service titled Strategic Analysis of the European Stem Cell Research Tools Market analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts are provided along with and end-user analysis. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools and protein biochemistry tools.
This analysis is available through our Clinical Diagnostics Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.
Dynamic Stem Cell Market Triggers Uptake of Related Research Tools
Stem cell research is very dynamic with research trends, focus, and approaches evolving at a rapid pace. The tools market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments. “Firms with the capacity to supply tools for stem cell research will increase as the science matures,” notes the analyst of this research. “Soon demand and supply will achieve a degree of equilibrium.” Already, a sizeable stem cell research products market has emerged. Another positive sign for the market has been the enhanced industry and academic collaborations.
A key step forward has been stem cell regulations in a few countries allowing the use of certain cell lines. In some countries such as France, for instance, stem cell regulations are being renewed for the procurement and use of stem cells. “Such trends indicate the potential for a regulatory climate that would be far less restrictive than the current scenario,” adds the analyst. “This, together with the prospect of diverse applications within the healthcare arena, is bolstering the future of the market.”
Technology and Investment Challenges Need to be Tackled
The lack of venture capitalists (VC) poses a grave challenge to continued market development. VC funding is driven by investment concerns, with companies bidding to double their money every few years to return revenue to the fund’s investors. As a high risk venture, stem cell technology does not exactly present an attractive investment proposition.
“While these are financial concerns, from the technological standpoint, the challenge remains to understand the basic biology behind stem cells,” remarks the analyst. “There is an urgent need to design and develop specific technology platforms that enhance the production, genetic stability and integration of transplanted cells.”
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
Frost & Sullivan Growth Partnership Services
Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results.
Our growth solutions support the entire growth process: